P193 proteins and nucleic acids, and uses thereof
CA 2383371 A1 · Owner: Field, Loren J. · Inventors: Tsai, Shih-Chong; Field, Loren J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described are nucleotide sequences coding for and regulating expression of a cell cycle regulatory protein, designated p193 and recombinant vectors and , host cells containing nucleotide sequences coding for and regulating expression of the protein sequence. Also described are methods for modifying the cell cycle of a cell by regulating p193 or its pathway. Methods for inducing apoptosis in cells are provided by increasing level of a proapoptotic p193 protein in the cells. Methods for suppressing apoptosis in or increasing the proliferative potential of cells are provided by reducing the level of pro-apoptotic p193 protein the cells and/or by interfering with the native p193 signal …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 23, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.